NEW YORK (GenomeWeb) – Healthcare private equity firm Shore Capital Partners announced on Tuesday that it has sold laboratory diagnostics service provider ClearPath Diagnostics to Laboratory Corporation of America.

The deal closed on Monday. Further details of the acquisition were not disclosed.